Addressing the Global Hepatitis C Crisis
Posted on February 19, 2015
The number of individuals suffering from the devastating consequences of chronic Hepatitis C (HCV) infection is increasing worldwide. HCV infection is typically asymptomatic for decades but up to 80% of people infected with HCV will develop chronic disease. Progressive liver fibrosis is an important consequence of chronic HCV infection, with resultant cirrhosis that may lead to liver failure (decompensation) and hepatocellular carcinoma (HCC). HCV is the leading cause of HCC, and it is likely that more cases of HCC, decompensated cirrhosis, and liver transplants due to HCV, will be observed in the coming years. While HCV-associated mortality is on the rise, to date, only 25% of infected patients have been diagnosed and only 5% cured. This is obviously a major global healthcare crisis.
The AJM Hepatitis C Resource Center (hepcresource.amjmed.com) was developed by the American Journal of Medicine (AJM) and Elsevier Multimedia Publishing to help address the global need for increased, effective HCV screening and diagnosis, and to highlight the promise of novel treatment regimens. To facilitate this global initiative, a Hep C webpage specifically tailored for audiences in India has also been launched, and is accessible through the Resource Center. Further APAC-specific webpages are in development.
Please visit the AJM Hepatitis C Resource Center and let us know your thoughts on the educational initiatives you encounter. We want to hear your opinions and your suggestions on how to improve the content.